195 related articles for article (PubMed ID: 18310504)
1. Blockade of endothelinergic receptors prevents development of proliferative vitreoretinopathy in mice.
Iribarne M; Ogawa L; Torbidoni V; Dodds CM; Dodds RA; Suburo AM
Am J Pathol; 2008 Apr; 172(4):1030-42. PubMed ID: 18310504
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
3. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
[TBL] [Abstract][Full Text] [Related]
4. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy.
Mori K; Gehlbach P; Ando A; Dyer G; Lipinsky E; Chaudhry AG; Hackett SF; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2001-6. PubMed ID: 12037011
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptors in light-induced retinal degeneration.
Torbidoni V; Iribarne M; Suburo AM
Exp Biol Med (Maywood); 2006 Jun; 231(6):1095-100. PubMed ID: 16741056
[TBL] [Abstract][Full Text] [Related]
6. A new model of proliferative vitreoretinopathy.
Frenzel EM; Neely KA; Walsh AW; Cameron JD; Gregerson DS
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2157-64. PubMed ID: 9761295
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice.
Gao Q; Wang W; Lan Y; Chen X; Yang W; Yuan Y; Tan J; Zong Y; Jiang Z
Int J Nanomedicine; 2013; 8():1563-72. PubMed ID: 23626468
[TBL] [Abstract][Full Text] [Related]
8. Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy.
Johnsen EO; Frøen RC; Albert R; Omdal BK; Sarang Z; Berta A; Nicolaissen B; Petrovski G; Moe MC
Exp Eye Res; 2012 May; 98():28-36. PubMed ID: 22465407
[TBL] [Abstract][Full Text] [Related]
9. A sustained dual drug delivery system for proliferative vitreoretinopathy.
Xiao Y; Choi KS; Warther D; Huffman K; Landeros S; Freeman WR; Sailor MJ; Cheng L
Drug Deliv; 2020 Dec; 27(1):1461-1473. PubMed ID: 33100053
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.
Szczesniak AM; Porter RF; Toguri JT; Borowska-Fielding J; Gebremeskel S; Siwakoti A; Johnston B; Lehmann C; Kelly ME
Neuropharmacology; 2017 Feb; 113(Pt B):627-638. PubMed ID: 27569993
[TBL] [Abstract][Full Text] [Related]
11. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR.
Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294
[TBL] [Abstract][Full Text] [Related]
12. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.
Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP
Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605
[TBL] [Abstract][Full Text] [Related]
13. Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy.
Charteris DG; Downie J; Aylward GW; Sethi C; Luthert P
Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):93-100. PubMed ID: 16612635
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis in proliferative vitreoretinopathy.
El Ghrably I; Powe DG; Orr G; Fischer D; McIntosh R; Dua HS; Tighe PJ
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1473-9. PubMed ID: 15111604
[TBL] [Abstract][Full Text] [Related]
15. A mouse model of proliferative vitreoretinopathy induced by dispase.
Cantó Soler MV; Gallo JE; Dodds RA; Suburo AM
Exp Eye Res; 2002 Nov; 75(5):491-504. PubMed ID: 12457862
[TBL] [Abstract][Full Text] [Related]
16. Glial cell expression of hepatocyte growth factor in vitreoretinal proliferative disease.
Hollborn M; Krausse C; Iandiev I; Yafai Y; Tenckhoff S; Bigl M; Schnurrbusch UE; Limb GA; Reichenbach A; Kohen L; Wolf S; Wiedemann P; Bringmann A
Lab Invest; 2004 Aug; 84(8):963-72. PubMed ID: 15156160
[TBL] [Abstract][Full Text] [Related]
17. Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening.
Pastor JC; Méndez MC; de la Fuente MA; Coco RM; García-Arumí J; Rodríguez de la Rúa E; Fernández N; Saornil MA; Gayoso MJ
Ophthalmic Res; 2006; 38(4):193-200. PubMed ID: 16679807
[TBL] [Abstract][Full Text] [Related]
18. Proliferation of the ciliary epithelium with retinal neuronal and photoreceptor cell differentiation in human eyes with retinal detachment and proliferative vitreoretinopathy.
Ducournau Y; Boscher C; Adelman RA; Guillaubey C; Schmidt-Morand D; Mosnier JF; Ducournau D
Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):409-23. PubMed ID: 21932075
[TBL] [Abstract][Full Text] [Related]
19. Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy.
Cui JZ; Chiu A; Maberley D; Ma P; Samad A; Matsubara JA
Eye (Lond); 2007 Feb; 21(2):200-8. PubMed ID: 16531976
[TBL] [Abstract][Full Text] [Related]
20. Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy.
Sethi CS; Lewis GP; Fisher SK; Leitner WP; Mann DL; Luthert PJ; Charteris DG
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):329-42. PubMed ID: 15623793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
